Arcadia Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Arcadia Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-280	Closed	-$9K	–	386
2017 Q2	$9K	Buy	+280	New	+$8.67K	﹤0.01%	329
2015 Q3	–	Sell	-200	Closed	-$11K	–	215
2015 Q2	$11K	Buy	+200	New	+$12.3K	﹤0.01%	210
2013 Q4	–	Sell	-53,084	Closed	-$2.01M	–	116
2013 Q3	$2.01M	Sell	53,084 -2,632	-5%	-$103K	0.52%	59
2013 Q2	$2.18M	Buy	+55,716	New	+$2.17M	0.62%	59

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arcadia Investment Management's TEVA Position: Q3 2017 in Review

Arcadia Investment Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 280 shares — an estimated $9K sold.

Arcadia Investment Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $2.18M in Q2 2013. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Arcadia Investment Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
Arcadia Investment Management sold 280 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $9K.
Arcadia Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 4 quarters.
Arcadia Investment Management's Teva Pharmaceutical Industries Limited position peaked at $2.18M in Q2 2013.
537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Arcadia Investment Management's 13F filing for Q3 2017, filed 18 Oct 2017.